DEA schedule
Is Imbruvica a controlled substance?
Imbruvica contains ibrutinib. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Imbruvica (ibrutinib) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and ibrutinib is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Imbruvica?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 6 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | ibrutinib is not on the list |
Imbruvica NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 57962-140 | Imbruvica | capsule | 140 mg/1 | Pharmacyclics LLC | None |
| 57962-070 | Imbruvica | capsule | 70 mg/1 | Pharmacyclics LLC | None |
| 57962-007 | Imbruvica | suspension | 70 mg/mL | Pharmacyclics LLC | None |
| 57962-014 | Imbruvica | tablet, film coated | 140 mg/1 | Pharmacyclics LLC | None |
| 57962-280 | Imbruvica | tablet, film coated | 280 mg/1 | Pharmacyclics LLC | None |
| 57962-420 | Imbruvica | tablet, film coated | 420 mg/1 | Pharmacyclics LLC | None |
Questions
Is Imbruvica a controlled substance?
No. Imbruvica (ibrutinib) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and ibrutinib is not on the DEA controlled substances list.
Is Imbruvica a narcotic?
No. Imbruvica (ibrutinib) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Kinase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.